Comment
doi: 10.1182/blood-2012-12-469981.
Haplo-BMT: which approach?
Affiliations
- PMID: 23372150
- DOI: 10.1182/blood-2012-12-469981
Item in Clipboard
Comment
Haplo-BMT: which approach?
Blood.
.
Free article
Abstract
In patients with hematologic malignancies, Di Bartolomeo et al report encouraging outcomes after transplantation of granulocyte-colony stimulating factor (G-CSF)– primed unmanipulated bone marrow from human leukocyte antigen (HLA)– haplotype mismatched (haploidentical) related donors, suggesting that this procedure makes haploidentical transplantation available in all transplant centers.
Comment on
-
Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies.Blood. 2013 Jan 31;121(5):849-57. doi: 10.1182/blood-2012-08-453399. Epub 2012 Nov 19. Blood. 2013. PMID: 23165479 Clinical Trial.
Similar articles
-
Cost and outcome in stem cell collections in HLA-haplo identical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilized blood and bone marrow for patients with hematologic malignancies.Transfus Apher Sci. 2010 Aug;43(1):23-8. doi: 10.1016/j.transci.2010.05.003. Epub 2010 Jun 15. Transfus Apher Sci. 2010. PMID: 20554478
-
Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies.Blood. 2013 Jan 31;121(5):849-57. doi: 10.1182/blood-2012-08-453399. Epub 2012 Nov 19. Blood. 2013. PMID: 23165479 Clinical Trial.
-
Stem cell collection in unmanipulated HLA-haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised blood and bone marrow for patients with haematologic malignancies: the impact of donor characteristics and procedural settings.Transfus Med. 2010 Jun;20(3):169-77. doi: 10.1111/j.1365-3148.2010.00990.x. Epub 2010 Feb 1. Transfus Med. 2010. PMID: 20136781 Free PMC article.
-
Granulocyte Colony-Stimulating Factor-Primed Unmanipulated Haploidentical Blood and Marrow Transplantation.Front Immunol. 2019 Nov 1;10:2516. doi: 10.3389/fimmu.2019.02516. eCollection 2019. Front Immunol. 2019. PMID: 31749802 Free PMC article. Review.
-
Modern approaches to HLA-haploidentical blood or marrow transplantation.Nat Rev Clin Oncol. 2016 Jan;13(1):10-24. doi: 10.1038/nrclinonc.2015.128. Epub 2015 Aug 25. Nat Rev Clin Oncol. 2016. PMID: 26305035 Free PMC article. Review.
Cited by
-
T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease.Bone Marrow Transplant. 2019 Aug;54(Suppl 2):775-779. doi: 10.1038/s41409-019-0597-y. Bone Marrow Transplant. 2019. PMID: 31431701 Review.
-
Second haploidentical bone marrow transplantation with antithymocyte antibody-containing conditioning regimen for graft failure in eight patients with severe aplastic anemia.Sci Rep. 2024 Jan 27;14(1):2293. doi: 10.1038/s41598-024-52917-4. Sci Rep. 2024. PMID: 38280947 Free PMC article.
-
A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality.Bone Marrow Transplant. 2014 Mar;49(3):376-81. doi: 10.1038/bmt.2013.178. Epub 2013 Nov 18. Bone Marrow Transplant. 2014. PMID: 24241579
-
Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation.Front Med. 2019 Feb;13(1):45-56. doi: 10.1007/s11684-017-0595-7. Epub 2018 Apr 19. Front Med. 2019. PMID: 29675688 Review.
-
T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis.Haematologica. 2015 Apr;100(4):558-64. doi: 10.3324/haematol.2014.111450. Epub 2015 Jan 30. Haematologica. 2015. PMID: 25637051 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
